Health Catalyst, Inc. (NASDAQ:HCAT) Receives Average Rating of “Hold” from Analysts

Health Catalyst, Inc. (NASDAQ:HCAT) has earned a consensus recommendation of “Hold” from the nine research firms that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating on the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $2.15.

Several equities research analysts recently commented on HCAT shares. Citigroup cut their price objective on shares of Health Catalyst from $2.50 to $2.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 11th. Wells Fargo & Company dropped their price target on Health Catalyst from $1.75 to $1.50 and set an “equal weight” rating on the stock in a research note on Thursday, August 13th. Weiss Ratings upgraded Health Catalyst from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, July 28th. Finally, Canaccord Genuity Group reaffirmed a “hold” rating and set a $1.80 price objective (down from $3.00) on shares of Health Catalyst in a research report on Thursday, August 20th.

Insider Buying and Selling

In other news, CEO Simeon Kohl bought 59,000 shares of the business’s stock in a transaction on Monday, September 14th. The shares were purchased at an average price of $1.79 per share, for a total transaction of $105,610.00. Following the purchase, the chief executive officer owned 2,856,385 shares of the company’s stock, valued at approximately $5,112,929.15. The trade was a 2.11% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 19.40% of the company’s stock.

Hedge Funds Weigh In On Health Catalyst

Several hedge funds have recently made changes to their positions in HCAT. Visionary Wealth Advisors acquired a new position in shares of Health Catalyst in the 2nd quarter valued at approximately $27,000. Hsbc Holdings PLC lifted its holdings in shares of Health Catalyst by 21.3% during the 1st quarter. Hsbc Holdings PLC now owns 98,868 shares of the company’s stock worth $123,000 after acquiring an additional 17,332 shares during the period. Whetstone Capital Advisors LLC boosted its position in shares of Health Catalyst by 0.5% during the 4th quarter. Whetstone Capital Advisors LLC now owns 3,750,377 shares of the company’s stock worth $8,963,000 after acquiring an additional 19,027 shares in the last quarter. AXQ Capital LP acquired a new stake in shares of Health Catalyst during the 2nd quarter worth approximately $38,000. Finally, Williams & Novak LLC increased its stake in Health Catalyst by 56.9% in the second quarter. Williams & Novak LLC now owns 53,607 shares of the company’s stock valued at $107,000 after acquiring an additional 19,442 shares during the last quarter. 85.00% of the stock is owned by institutional investors.

Health Catalyst Stock Performance

Shares of HCAT stock opened at $1.76 on Thursday. The company has a debt-to-equity ratio of 1.51, a quick ratio of 2.70 and a current ratio of 2.70. The company has a market capitalization of $132.46 million, a P/E ratio of -0.48 and a beta of 1.54. The company’s 50 day moving average price is $1.78 and its two-hundred day moving average price is $1.65. Health Catalyst has a 52 week low of $0.96 and a 52 week high of $3.62.

Health Catalyst (NASDAQ:HCAT) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.04 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.01. Health Catalyst had a negative net margin of 90.61% and a negative return on equity of 1.83%. The firm had revenue of $70.49 million for the quarter, compared to analyst estimates of $69.09 million. On average, analysts expect that Health Catalyst will post -0.18 earnings per share for the current fiscal year.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services for healthcare organizations. Its solutions are designed to help hospitals, health systems and other providers organize clinical, operational and financial data, identify opportunities for improvement, and support more informed decisions.

The company’s offerings include its Health Catalyst Data Operating System, which integrates and manages healthcare data from multiple sources, along with analytics applications, artificial intelligence and machine-learning capabilities, and tools for population health, quality improvement, cost management and operational performance.